AMDA - Acid Maltase Deficiency Association

The Official Website of the Acid Maltase Deficiency Association

It is difficult to say what is impossible for the dreams of yesterday are the hopes of today and the reality of tomorrow. - Robert H. Goddard

Recent | Archives

News

Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe

Posted on: February 27, 2009 - Filed under

View complete article

Other News

View complete archive

Get Involved

Your generous contribution will go a long way into improving the quality of life of Pompe Disease Patients worldwide.

Recently Added Items

AMDA 2010 Research Grant Opportunity was posted in News, last July 31, 2010
Kaia Messina was posted in Member Memorials, last July 22, 2010
Kaia Messina was posted in Patients, last July 19, 2010
George Jacob Thomas was posted in Patients, last July 19, 2010
Hearing loss in Pompe disease revisited: results from a study of 24 children was posted in Publications, last July 01, 2010

Home | News | About | Research | Patients | Initiatives | Editorials | Links | Contact

© 2009 Acid Maltase Deficiency Association